right inferior canaliculus in a 77-year-old man [ Fig. 1 ]. The lesion was previously subjected to biopsy by his dermatologist with histologic results of nodular BCC. Chronic epiphora was not noted. Syringing of the canaliculus by means of a cannula of 25 G showed patency of them. Total surgical excision would have caused a loss of the permeable canaliculus. Hence, intralesional treatment with recombinant INF alone was proposed. Aft er informed consent was obtained, INF alpha 2b was injected three times a week for three weeks with 1.5 x 10 (6) IU (0.15 ml) per injection. The total dose received was 13.5 x 10 (6) IU. The lesion persisted during the follow-up of six months [ Fig. 2 ]. Wide surgical resection was then proposed. The histologic study of the resected mass conÞ rmed the persistence of nodular BCC. During a year of follow-up no recurrences have been noticed. However, a cicatricial medial ectropion was present.
We used the same dosage as reported in the Þ rst study 3 which had 100% success rate for eight cutaneous BCCs aft er two months of therapy. However, later studies reported complete regression in only 67% of patients with cutaneous BCC treated with intralesional INF alone.
4 A 90.9% success rate has been observed in the eyelids.
2 In this study, the authors used intralesional INF alpha 2b as an adjunctive treatment aft er the resection of aggressive BCC and reconstruction. The patient in the presented case had undergone a prior minor biopsy but not a wide resection. It is possible that a wide resection followed by intralesional INF could att ain bett er satisfactory results in BCC around the canaliculus. Surgical procedures may also stimulate the immune system and prevent recurrences. We have observed the absence of recurrence during follow-up in some cases in which pathology studies revealed involved margins aft er resection. In these cases, intralesional INF alpha 2b may be a useful adjunctive treatment, as has been proposed. 2 In conclusion, intralesional INF alpha 2b cannot be the Þ rst choice in the treatment of BCC around the canaliculus.
Chronic bilateral lacrimal gland pseudotumor in an adult
Dear Editor, A 38-year-old male presented to us with a history of bilateral painless upper eyelid swelling over the lateral region increasing slowly in size over a period of seven years. On examination there was fullness at the lateral aspect of the upper eyelid in either eye giving rise to S-shaped ptosis. There was associated mild injection of the palpebral portion of the lacrimal gland and the adjacent conjunctiva. Best corrected visual acuity was 20/20 in both eyes. Other ocular and systemic examinations were normal.
Ultrasound of the lesions showed a heterogeneous mass in the lacrimal gland area. Computed tomography scan revealed heterogeneous lesion in both lacrimal glands extending into preseptal tissue with no evidence of bony erosion [ Fig. 1 ]. Fine needle aspiration cytology (FNAC) from the right lacrimal gland was suggestive of pleomorphic adenoma, however, incisional biopsy was advised for conÞ rmation. A week later, incisional biopsy was undertaken, which showed lymphocytes, plasma cells and other features suggestive of pseudotumor. He was started on oral prednisolone 1.5 mg/kg/day, with which he showed dramatic response. The swelling disappeared by second week of treatment. Steroids were tapered over the next two months. However, he presented again with similar swellings bilaterally six months later [ Fig. 2 ]. The same treatment was instituted but this time steroids were tapered very slowly over a period of six months. He did not have any further recurrence in the last one year.
Idiopathic orbital inflammation, also known as orbital pseudotumor (OP), is a term describing a spectrum of idiopathic, non-neoplastic, non-infectious, space-occupying orbital lesions without identiÞ able local or systemic cause.
1 It may present as dacroadenitis, sclerotenovitis or as a diff use anterior soft tissue inß ammation.
2 Bilateral OP may be seen in children, however, unilateral disease is the rule in adults.
3
Isolated bilateral lacrimal gland pseudotumor in adults is exceedingly rare. 4 Lacrimal gland pseudotumors tend to be recurrent and refractory to treatment. Pseudotumor, solely limited to the lacrimal gland may harbor malignancies, especially if chronic enlargement of gland is present alike our case. 6 The FNAC diagnosis and differentiation of benign from malignant primary orbital lymphoid lesions is often difficult.
7 When the results are equivocal open biopsies are recommended for conÞ rmation as was required in our case.
This case underscores the need of prolonged systemic steroid therapy in cases of bilateral lacrimal gland pseudotumor and the limited utility of FNAC in establishing the diagnosis of lacrimal gland diseases.
